GridAI Technologies Corp. (ticker: GRDX) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of GRDX's SEC filings surfaces 7 active risk signals, including 6 late-filing signals, and 1 auditor-change signal. GRDX reported $36K in revenue and -$6.39M for the period ending 2025-12-31, with operating cash flow of -$5.70M. Cash and equivalents stood at $900K (up 450.4% year-over-year). Total assets of $48.55M exceed total liabilities of $19.72M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
GRDX SEC Filings
Full cached SEC EDGAR filing history for GRDX, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.